505 research outputs found

    Viewing Nature Scenes Positively Affects Recovery of Autonomic Function Following Acute-Mental Stress

    Get PDF
    A randomized crossover study explored whether viewing different scenes prior to a stressor altered autonomic function during the recovery from the stressor. The two scenes were (a) nature (composed of trees, grass, fields) or (b) built (composed of man-made, urban scenes lacking natural characteristics) environments. Autonomic function was assessed using noninvasive techniques of heart rate variability; in particular, time domain analyses evaluated parasympathetic activity, using root-mean-square of successive differences (RMSSD). During stress, secondary cardiovascular markers (heart rate, systolic and diastolic blood pressure) showed significant increases from baseline which did not differ between the two viewing conditions. Parasympathetic activity, however, was significantly higher in recovery following the stressor in the viewing scenes of nature condition compared to viewing scenes depicting built environments (RMSSD; 50.0 ± 31.3 vs 34.8 ± 14.8 ms). Thus, viewing nature scenes prior to a stressor alters autonomic activity in the recovery period. The secondary aim was to examine autonomic function during viewing of the two scenes. Standard deviation of R-R intervals (SDRR), as change from baseline, during the first 5 min of viewing nature scenes was greater than during built scenes. Overall, this suggests that nature can elicit improvements in the recovery process following a stressor. © 2013 American Chemical Society

    Transcranial Direct Current Stimulation (tDCS): A Beginner's Guide for Design and Implementation

    Get PDF
    Transcranial direct current stimulation (tDCS) is a popular brain stimulation method that is used to modulate cortical excitability, producing facilitatory or inhibitory effects upon a variety of behaviors. There is, however, a current lack of consensus between studies, with many results suggesting that polarity-specific effects are difficult to obtain. This article explores some of these differences and highlights the experimental parameters that may underlie their occurrence. We provide a general, practical snapshot of tDCS methodology, including what it is used for, how to use it, and considerations for designing an effective and safe experiment. Our aim is to equip researchers who are new to tDCS with the essential knowledge so that they can make informed and well-rounded decisions when designing and running successful experiments. By summarizing the varied approaches, stimulation parameters, and outcomes, this article should help inform future tDCS research in a variety of fields

    PTPN11 mutations are not responsible for the Cardiofaciocutaneous (CFC) syndrome

    Get PDF
    Cardiofaciocutaneous (CFC) syndrome is a multiple congenital anomalies/mental retardation syndrome characterized by congenital heart defects, characteristic facial appearance, short stature, ectodermal abnormalities and mental retardation. It was described in 1986, and to date is of unknown genetic etiology. All reported cases are sporadic, born to non-consanguineous parents and have apparently normal chromosomes. Noonan and Costello syndromes remain its main differential diagnosis. the recent finding of PTPN11 missense mutations in 45-50% of the Noonan patients studied with penetrance of almost 100% and the fact that in animals mutations of this gene cause defects of semilunar valvulogenesis, made PTPN11 mutation screening in CFC patients a matter of interest. We sequenced the entire coding region of the PTPN11 gene in ten well-characterised CFC patients and found no base changes. We also studied PTPN11 cDNA in our patients and demonstrated that there are no interstitial deletions either. the genetic cause of CFC syndrome remains unknown, and PTPN11 can be reasonably excluded as a candidate gene for the CFC syndrome, which we regard as molecular evidence that CFC and Noonan syndromes are distinct genetic entities.Univ Sacred Heart, Ist Genet Med, I-00168 Rome, ItalyUniversidade Federal de São Paulo, Escola Paulista Med, Ctr Med Genet, São Paulo, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Dept Dermatol, São Paulo, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Ctr Med Genet, São Paulo, BrazilUniversidade Federal de São Paulo, Escola Paulista Med, Dept Dermatol, São Paulo, BrazilWeb of Scienc

    Transcranial direct current stimulation over multiple days improves learning and maintenance of a novel vocabulary

    Get PDF
    Introduction: Recently, growing interest emerged in the enhancement of human potential by means of non-invasive brain stimulation. In particular, anodal transcranial direct current stimulation (atDCS) has been shown to exert beneficial effects on motor and higher cognitive functions. However, the majority of transcranial direct current stimulation (tDCS) studies have assessed effects of single stimulation sessions that are mediated by transient neural modulation. Studies assessing the impact of multiple stimulation sessions on learning that may induce long-lasting behavioural and neural changes are scarce and have not yet been accomplished in the language domain in healthy individuals

    Acute and repetitive fronto-cerebellar tDCS stimulation improves mood in non-depressed participants

    Get PDF

    Amino acid conjugation of oxIAA is a secondary metabolic regulation involved in auxin homeostasis

    Get PDF
    Dynamic regulation of the concentration of the natural auxin indole-3-acetic acid (IAA) is essential to coordinate most physiological and developmental processes and responses to environmental changes (reviewed in Friml, 2022). Auxin inactivation plays a crucial role in auxin homeostasis and metabolism. The primary enzymes involved in auxin metabolism have been known for some time. Members of the acyl acid amide synthetases belonging to the GRETCHEN HAGEN 3 (GH3) and the amidohydrolase IAA-LEUCINE RESISTANT 1 (ILR1) and ILR1-like (ILL) families catalyze the conjugation of IAA to amino acids and hydrolysis of the IAA-amino acid conjugates, respectively (LeClere et al., 2002; Staswick et al., 2005). The DIOXIGENASE FOR AUXIN OXIDATION (DAO) enzymes were shown to catalyze the oxidation of IAA to form oxIAA (Porco et al., 2016; Zhang et al., 2016). Albeit these IAA- inactivating enzymes appeared to participate in different catabolic routes, very recently, it was reported that GH3, ILR1, and DAO are part of a single linear pathway rather than two distinct ways (Hayashi et al., 2021). According to this model, IAA is mainly inactivated by GH3 enzymes, DAO functions as an oxidase of IAA-amino acid conjugates to produce oxIAA-amino acid conjugates downstream of GH3, and oxIAA is produced from oxIAA-amino acid hydrolysis by ILR1. Therefore, DAO and ILR1 enzymes appeared to play a role in this pathway that differs from that assigned initially. Although GH3 enzymes are known to possess catalytic promiscuity accepting various substrates and amino acids, a possible additional role of GH3s in auxin inactivation was not investigated (Staswick et al., 2005; Westfall et al., 2012). Besides, while the new model proposed by Hayashi et al. (2021) was described to occur in angiosperms, whether it operates in nonflowering species remains unknown (Ross & G elinas- Marion, 2021). GRETCHEN HAGEN 3 proteins are highly conserved all over the plant kingdom, whereas DAO and DAO-like enzymes have specifically evolved with angiosperms (Okrent & Wildermurth, 2011; Brunoni et al., 2020; Kaneko et al., 2020; Takehara et al., 2020). Here, we report the evidence of oxIAA-amino acid conjugation being catalyzed by the group of IAA-conjugating enzymes belonging to the Group II of GH3s. Our work suggests that the contribution of this pathway to auxin homeostasis is species-dependent

    Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study

    Get PDF
    Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world. Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231. Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05–2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001). Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication
    corecore